Results 31 to 40 of about 5,332,530 (372)

Atrial fibrillation and survival in colorectal cancer [PDF]

open access: yes, 2004
BACKGROUND: Survival in colorectal cancer may correlate with the degree of systemic inflammatory response to the tumour. Atrial fibrillation may be regarded as an inflammatory complication.
Gladwish, Kelly M   +4 more
core   +3 more sources

Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer

open access: yesCancer Cell International, 2020
Background Survival outcomes are significantly different in stage II colorectal cancer (CRC) patients with diverse clinicopathological features. The objective of this study is to establish a credible prognostic nomogram incorporating easily obtained ...
Shaobo Mo   +7 more
doaj   +1 more source

Title: Risk Factors for the Diagnosis of Colorectal Cancer

open access: yesCancer Control: Journal of the Moffitt Cancer Cente, 2022
Background Colorectal cancer defined as cancer of the colon or rectum, is the third most frequently diagnosed cancer in men and the second in women, and, according to the World Health Organization database GLOBOCAN, it accounts for nearly 1.4 million new
A. Lewandowska   +4 more
semanticscholar   +1 more source

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

open access: yesNew England Journal of Medicine, 2004
BACKGROUND Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclinical and clinical activity against metastatic colorectal cancer, particularly in combination with chemotherapy. METHODS Of 813 patients
H. Hurwitz   +14 more
semanticscholar   +1 more source

Analysis of adenoma detection rate of colonoscopy among trainees [PDF]

open access: yesAnnals of Coloproctology
Purpose To analyze adenoma detection rate (ADR) and related quality indicators of colonoscopy among trainees and make recommendations for appropriate colonoscopy training.
Young Min Song   +7 more
doaj   +1 more source

Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

open access: yesJournal of Experimental & Clinical Cancer Research, 2018
Background Precision medicine calls for an early indicator of treatment efficiency. Circulating tumor DNA (ctDNA) is a promising marker in this setting. Our prospective study explored the association between disease development and change of ctDNA during
C. B. Thomsen   +5 more
doaj   +1 more source

The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision

open access: yesBMC Cancer, 2022
Background To study the pattern and treatment outcome of rectal cancer (RC) with concurrent locoregional recurrence (LR) and distant metastasis (DM) after total mesorectal excision (TME) and to identify patient-, disease-, and treatment-related factors ...
Yikuan Chen   +7 more
doaj   +1 more source

BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibition. [PDF]

open access: yes, 2016
The proteasome inhibitor MLN9708 is an orally administered drug that is hydrolyzed into its active form, MLN2238 (ixazomib). Compared with Bortezomib, MLN2238 has a shorter proteasome dissociation half-life and a lower incidence and severity of ...
Barkhouse, Darryll   +7 more
core   +2 more sources

Increased prevalence of colorectal adenomas in women with breast cancer [PDF]

open access: yes, 2005
Background: The frequency of colorectal adenomas and carcinomas was investigated in a large cohort of women with breast cancer in comparison with matched controls, since data on the occurrence of second tumors in women with breast cancer is controversial.
Bayerdörffer, Ekkehard   +8 more
core   +1 more source

Comprehensive review of targeted therapy for colorectal cancer

open access: yesSignal Transduction and Targeted Therapy, 2020
Colorectal cancer (CRC) is among the most lethal and prevalent malignancies in the world and was responsible for nearly 881,000 cancer-related deaths in 2018. Surgery and chemotherapy have long been the first choices for cancer patients.
Yuanhong Xie, Yingxuan Chen, J. Fang
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy